previous compound ID: 845 next compound
InChIKey: HJMQDJPMQIHLPB-UHFFFAOYSA-N
SMILES: COC1=C(C=CC(=C1)C2=NNC(=O)C=C2)OC(F)F

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "R Robert" "DY Thomas" "B Kus" "E Matthes" "J Goepp" "D Rotin" "GW Carlile" "J Liao" "SD Macknight"

chemical graph of compound 845





CID is 5723
synonyms found at PubChem are:
zardaverine, 101975-10-4, Zardaverina, Zardaverinum, Zardaverine [INN], Zardaverinum [INN-Latin], UNII-TQ358GWH6Y, Zardaverina [INN-Spanish], 6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE, C12H10F2N2O3, 6-(4-(Difluoromethoxy)-3-methoxyphenyl)-3(2H)-pyridazinone, TQ358GWH6Y, CHEMBL313842, CHEBI:46548, HJMQDJPMQIHLPB-UHFFFAOYSA-N, 6-(4-Difluoromethoxy-3-methoxyphenyl)-3(2H)-pyridazinone, NCGC00016106-04, 6-[4-(difluoromethoxy)-3-methoxyphenyl]pyridazin-3(2H)-one, 3(2H)-Pyridazinone,6-[4-(difluoromethoxy)-3-methoxyphenyl]-, CAS-101975-10-4, 3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]- [CAS], DSSTox_CID_22559, DSSTox_RID_80048, DSSTox_GSID_42559, 6-(4-(difluoromethoxy)-3-methoxyphenyl)pyridazin-3(2H)-one, 6-[4-(Difluoromethoxy)-3-methoxyphenyl]-3(2H)-pyridazinone, SMR000449313, SR-01000076204, Zaradaverine, 1mkd, 1xor, Tocris-1046, ACMC-20ccb1, AC1L1KZT, AC1Q6BYY, Prestwick0_000977, Prestwick1_000977, Prestwick2_000977, Prestwick3_000977, Lopac-Z-3003, D0F0CS, UPCMLD-DP159, Lopac0_001260, SCHEMBL13334, BSPBio_001013, BSPBio_001346, KBioGR_000066, KBioSS_000066, MLS000758207, MLS001401422, SPBio_002924, BPBio1_001115, DTXSID8042559, SCHEMBL14810549, UPCMLD-DP159:001, UPCMLD-DP159:002, BDBM14769, CTK4A0496, KBio2_000066, KBio2_002634, KBio2_005202, KBio3_000131, KBio3_000132, 3-pyridazinol, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-, 6-(4-difluoromethoxy-3-methoxyphenyl)-3(2H)pyridazinone, MolPort-003-960-230, MolPort-044-724-428, Bio2_000066, Bio2_000546, HMS1361D08, HMS1571C15, HMS1791D08, HMS1989D08, HMS2051O09, HMS2090L06, HMS2098C15, HMS2235H08, HMS3267C08, HMS3370L18, HMS3393O09, HMS3402D08, HMS3715C15, BCP06509, ZINC9230249, Tox21_110307, 4165AH, BS0210, MFCD00867059, AKOS024456348, Tox21_110307_1, Zardaverine phosphodiesterase inhibitor, CCG-100782, CCG-205334, CS-1011, DB02918, NC00032, Zardaverine, phosphodiesterase inhibitor, IDI1_033816, NCGC00016106-01, NCGC00016106-02, NCGC00016106-03, NCGC00016106-05, NCGC00016106-06, NCGC00016106-07, NCGC00016106-08, NCGC00016106-09, NCGC00016106-10, NCGC00016106-11, NCGC00016106-13, NCGC00024963-01, NCGC00024963-02, NCGC00024963-03, NCGC00024963-04, NCGC00024963-05, CC-35668, CPD000449313, HY-15485, SAM001247053, SBI-0051227.P002, LS-171799, AB00513983, EU-0101260, FT-0631019, W-5158, Z 3003, AB00513983-03, C-16835, J-000529, SR-01000076204-1, SR-01000076204-3, SR-01000076204-5, BRD-K37561857-001-04-9, BRD-K37561857-001-06-4, BRD-K37561857-001-13-0, 6-(4-difluoromethoxy-3-methoxy-phenyl)-3[2h]-pyridazinone, 3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-2,3-dihydropyridazin-3-one, 6-(3,4-Dimethoxy-phenyl)-4,5-dimethyl-4,5-dihydro-2H-pyridazin-3-one